Munir Ahmad Abu-Helalah1, Hussam Ahmad Alshraideh2, Moh'd Da'na3, Mo'tasem Al-Hanaqtah4, Anas Abuseif5, Kamal Arqoob6, Abdelrahman Ajaj7. 1. Department of Public Health, Faculty of Medicine, Mutah University, Mutah 61710, Karak, Jordan. mabuhelalah@yahoo.co.uk. 2. Department of Industrial Engineering, Faculty of Engineering, Jordan University of Science and Technology, Irbid, Jordan. 3. Ministry of Health, Karak Teaching Hospital, Karak, Jordan. 4. Oncology Center, Royal Medical Services, Amman, Jordan. 5. Ministry of Health, AlBashir Teaching Hospital, Ammam, Jordan. 6. Directorate of Non-Communicable Diseases, Ministry of Health Jordan, Ammam, Jordan. 7. Department of Radiation Oncology, AlBashir Hospital, Ministry of Health, Amman, Jordan.
Abstract
PURPOSE: Colorectal cancer (CRC) ranked first among cancers reported in males and second among cancers reported in females in Jordan in 2010. There has been no specific CRC-control programme in Jordan. Additionally, there has been no published study from Jordan or its neighbours on patient delays in presentation, diagnosis or treatment. Therefore, we conducted this study to assess these important quality indicators aiming to improve prognosis for CRC and to provide baseline data for future health promotion programmes for CRC in Jordan. METHODS: This project was a cross-sectional study on CRC patients at Al Bashir Hospital, Ministry of Health, and at the Military Oncology Centre of the Jordanian Royal Medical Services. RESULTS: The total number of participants was 189. The proportion of patients with presentation delay, diagnosis delay or treatment delay was 33.9, 68.1 and 32.6%, respectively. The main reasons reported for delay in presentation were lack of knowledge that symptoms were suggestive of cancer (58.5%), misdiagnosis by physicians or pharmacists (38.4%) or the patient did not want to visit a doctor (3.1%). Predictors of delay and mean time for presentation, diagnosis and treatment were identified. CONCLUSIONS: Our results revealed that CRC patients in Jordan experience delays in presentation, Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation diagnosis, and, to a lesser degree, in treatment. This could justify the advanced stages at diagnosis and poor outcomes for CRC patients. Our findings provide baseline information for future CRC-control programmes in Jordan. We recommend that CRC prevention programmes in Jordan focus on early detection of CRC and target both patients and physicians.
PURPOSE:Colorectal cancer (CRC) ranked first among cancers reported in males and second among cancers reported in females in Jordan in 2010. There has been no specific CRC-control programme in Jordan. Additionally, there has been no published study from Jordan or its neighbours on patient delays in presentation, diagnosis or treatment. Therefore, we conducted this study to assess these important quality indicators aiming to improve prognosis for CRC and to provide baseline data for future health promotion programmes for CRC in Jordan. METHODS: This project was a cross-sectional study on CRC patients at Al Bashir Hospital, Ministry of Health, and at the Military Oncology Centre of the Jordanian Royal Medical Services. RESULTS: The total number of participants was 189. The proportion of patients with presentation delay, diagnosis delay or treatment delay was 33.9, 68.1 and 32.6%, respectively. The main reasons reported for delay in presentation were lack of knowledge that symptoms were suggestive of cancer (58.5%), misdiagnosis by physicians or pharmacists (38.4%) or the patient did not want to visit a doctor (3.1%). Predictors of delay and mean time for presentation, diagnosis and treatment were identified. CONCLUSIONS: Our results revealed that CRC patients in Jordan experience delays in presentation, Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation diagnosis, and, to a lesser degree, in treatment. This could justify the advanced stages at diagnosis and poor outcomes for CRC patients. Our findings provide baseline information for future CRC-control programmes in Jordan. We recommend that CRC prevention programmes in Jordan focus on early detection of CRC and target both patients and physicians.
Authors: Phyllis A Wingo; Cheryll J Cardinez; Sarah H Landis; Robert T Greenlee; Lynn A G Ries; Robert N Anderson; Michael J Thun Journal: Cancer Date: 2003-06-15 Impact factor: 6.860
Authors: Tin Tin Su; Jun Yan Goh; Jackson Tan; Abdul Rahim Muhaimah; Yoganathan Pigeneswaren; Nasirin Sallamun Khairun; Abdul Wahab Normazidah; Devi Kunasekaran Tharisini; Hazreen Abd Majid Journal: BMC Cancer Date: 2013-08-07 Impact factor: 4.430
Authors: Zeta Chow; Patrick Osterhaus; Bin Huang; Quan Chen; Nancy Schoenberg; Mark Dignan; B Mark Evers; Avinash Bhakta Journal: J Surg Res Date: 2020-10-20 Impact factor: 2.192
Authors: Irene Zarcos-Pedrinaci; Alberto Fernández-López; Teresa Téllez; Francisco Rivas-Ruiz; Antonio Rueda; María Manuela Morales Suarez-Varela; Eduardo Briones; Marisa Baré; Antonio Escobar; Cristina Sarasqueta; Nerea Fernández de Larrea; Urko Aguirre; José María Quintana; Maximino Redondo Journal: Oncotarget Date: 2017-05-30
Authors: Grace McCutchan; Bahr Weiss; Harriet Quinn-Scoggins; Anh Dao; Tom Downs; Yunfeng Deng; Ha Ho; Lam Trung; Jon Emery; Kate Brain Journal: BMJ Glob Health Date: 2021-02
Authors: Francisco A Montiel Ishino; Emmanuel A Odame; Kevin Villalobos; Martin Whiteside; Hadii Mamudu; Faustine Williams Journal: J Public Health Manag Pract Date: 2022 Mar-Apr 01